These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12. Yamanaka R; Zullo SA; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG Neurosurg Focus; 2000 Dec; 9(6):e7. PubMed ID: 16817690 [TBL] [Abstract][Full Text] [Related]
17. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12. Yamanaka R; Zullo SA; Ramsey J; Yajima N; Tsuchiya N; Tanaka R; Blaese M; Xanthopoulos KG J Neurosurg; 2002 Sep; 97(3):611-8. PubMed ID: 12296646 [TBL] [Abstract][Full Text] [Related]
18. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308 [TBL] [Abstract][Full Text] [Related]
19. Alphavirus vectors as tools in cancer gene therapy. Lundstrom K Technol Cancer Res Treat; 2002 Feb; 1(1):83-8. PubMed ID: 12614181 [TBL] [Abstract][Full Text] [Related]
20. Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses. Ballesteros-Briones MC; Martisova E; Casales E; Silva-Pilipich N; Buñuales M; Galindo J; Mancheño U; Gorraiz M; Lasarte JJ; Kochan G; Escors D; Sanchez-Paulete AR; Melero I; Prieto J; Hernandez-Alcoceba R; Hervas-Stubbs S; Smerdou C Mol Ther; 2019 Nov; 27(11):1892-1905. PubMed ID: 31563534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]